Biochemical markers of bone formation in the study of postmenopausal osteoporosis
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 8 (2) , 147-151
- https://doi.org/10.1007/bf02672511
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Six osteocalcin assays comparedClinical Chemistry, 1994
- Commercial assays for serum osteocalcin give clinically discordant resultsClinical Chemistry, 1994
- Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitroJournal of Bone and Mineral Research, 1994
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1993
- Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.Journal of Clinical Endocrinology & Metabolism, 1993
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicineClinical Chemistry, 1993
- Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseasesJournal of Bone and Mineral Research, 1992
- Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosisJournal of Bone and Mineral Research, 1991
- Bone gla protein (osteocalcin) assay standardization reportJournal of Bone and Mineral Research, 1990
- Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphataseJournal of Bone and Mineral Research, 1987